Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1

Conditions

Skin Neoplasms 3Sarcoma, Kaposi 2Melanoma 2HIV Infections 2Squamous Cell Carcinoma of Head and Neck 1Neoplasms, Unknown Primary 1Nasopharyngeal Neoplasms 1Head and Neck Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

pembrolizumab 1motexafin gadolinium 1atezolizumab 1Semaxinib 1Ritonavir 1Radiotherapy 1Oxaliplatin 1Irinotecan 1Indinavir 1Immunoglobulin G 1Doxorubicin 1Disulfides 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Neoplasms × Semaxinib × Dermatologic × Clear all
NCT00006361 2009-12-04

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

National Cancer Institute (NCI)

Phase 2 Completed
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡